Heart health check for fatty liver disease patients
Part of Digestive system, Heart & circulation clinical trials.
This study looks at heart health in people with fatty liver disease (MASLD) by measuring calcium in the heart's arteries with a special scan, to see if they are at risk for heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with fatty liver disease (MASLD), for example by an ultrasound or a special scan called FibroScan.
- You must have no symptoms of heart disease, such as chest pain or shortness of breath.
- You must have had recent liver fibrosis tests (FIB-4 or APRI) and other lab work done.
- You must not have had a heart attack, stent, or bypass surgery.
- You must not have had a stroke or problems with blood flow in your legs.
- You must not have other liver diseases like hepatitis B or C, or drink heavy amounts of alcohol.
- You must not have advanced kidney disease, advanced cancer, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study uses ultrasound to measure fat in your liver and check your heart's function to better understand your risk for heart problems. It may help doctors find ways to prevent heart disease in people with fatty liver disease.
This study looks at a simple blood test (mean platelet volume, or MPV) to see if it can help predict heart attacks in people with fatty liver disease. If it works, doctors might use this test to identify at-risk patients earlier and prevent heart problems.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
Hear when a new Coronary Artery Calcification trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.